AKT1 and breast cancer: Another study showed [37] that AA (50 mg·kg−1) inhibited the growth of breast cancer xenograft tumors by regulating the PI3K/AKT signaling pathway and down-regulating the expression of proteins such as WAVE3, p53, p-PI3K, and p-AKT, resulting in a tumor inhibition rate of 59.55%.